Associated Banc Corp decreased its stake in shares of Roche Holding AG (OTCMKTS:RHHBY – Free Report) by 2.1% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 44,340 shares of the company’s stock after selling 930 shares during the period. Associated Banc Corp’s holdings in Roche were worth $1,778,000 at the end of the most recent reporting period.
A number of other hedge funds also recently made changes to their positions in the stock. AlphaMark Advisors LLC purchased a new stake in shares of Roche during the third quarter valued at approximately $149,000. GAMMA Investing LLC increased its position in shares of Roche by 61.5% during the second quarter. GAMMA Investing LLC now owns 5,038 shares of the company’s stock worth $175,000 after acquiring an additional 1,919 shares during the last quarter. Verity Asset Management Inc. purchased a new position in Roche in the third quarter valued at about $253,000. Archer Investment Corp increased its holdings in Roche by 10.6% during the 2nd quarter. Archer Investment Corp now owns 6,810 shares of the company’s stock worth $236,000 after purchasing an additional 652 shares during the last quarter. Finally, Waldron Private Wealth LLC purchased a new position in shares of Roche during the 2nd quarter valued at approximately $263,000.
Analyst Ratings Changes
Several brokerages have issued reports on RHHBY. Bank of America upgraded Roche from a “neutral” rating to a “buy” rating in a research note on Friday, September 13th. Deutsche Bank Aktiengesellschaft lowered shares of Roche from a “hold” rating to a “sell” rating in a research note on Friday, September 13th. Three analysts have rated the stock with a sell rating, one has issued a hold rating and one has assigned a buy rating to the company. According to data from MarketBeat.com, Roche currently has an average rating of “Hold”.
Roche Stock Performance
RHHBY opened at $35.62 on Tuesday. The stock’s 50 day moving average price is $38.53 and its 200 day moving average price is $37.39. Roche Holding AG has a 12 month low of $29.20 and a 12 month high of $42.43.
Roche Company Profile
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.
See Also
- Five stocks we like better than Roche
- With Risk Tolerance, One Size Does Not Fit All
- MicroStrategy Stock Could Gain 50%, But Be Ready for Volatility
- What Investors Need to Know to Beat the Market
- 3 Key Analyst Upgrades: Why These Stocks Are Getting a Boost
- 3 Fintech Stocks With Good 2021 Prospects
- Abacus Life’s CEO on Cracking the Code of Longevity Returns
Want to see what other hedge funds are holding RHHBY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Roche Holding AG (OTCMKTS:RHHBY – Free Report).
Receive News & Ratings for Roche Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche and related companies with MarketBeat.com's FREE daily email newsletter.